Valuation: Celltrion, Inc.

Market Cap 40,981B 29.5B 25.72B 24.29B 22.06B 41.32B 2,831B 41.5B 291B 112B 1,439B 111B 108B 4,630B P/E 2026 *
27.2x
P/E 2027 * 23.2x
Enterprise Value 43.2B 31.1M 27.12M 25.61M 23.25M 43.57M 2.98B 43.75M 307M 118M 1.52B 117M 114M 4.88B EV / Sales 2026 *
7.83x
EV / Sales 2027 * 6.68x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.44%
1 day-0.50%
1 week-0.77%
Current month-5.03%
1 month-10.75%
3 months+2.75%
6 months-8.56%
Current year+4.07%
1 week 174,600
Extreme 174600
182,800
1 month 174,600
Extreme 174600
202,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-0.77%+11.86%+40.41% 29.83B
+0.11%+2.71%+0.33%+28.59% 46.18B
-1.18%+1.70%+39.97%+27.17% 44.35B
-3.11%-6.46%+321.49%+516.23% 42.21B
-1.10%+0.97%+2.04%+67.48% 40.19B
-0.81%+3.90%+21.62%+123.53% 17.17B
+0.14%-9.21% - - 15.7B
-0.57%+8.12%+22.15%+38.93% 15.32B
-4.15%-3.74%-9.17%-38.03% 13.09B
-1.70%-0.50%+76.36%+31.49% 13.45B
Average -1.27%+1.32%+54.07%+92.87% 27.75B
Weighted average by Cap. -1.18%+1.47%+66.51%+117.95%

Financials

2026 *2027 *
Net sales 5,521B 3.97B 3.47B 3.27B 2.97B 5.57B 381B 5.59B 39.2B 15.13B 194B 14.93B 14.6B 624B 6,344B 4.57B 3.98B 3.76B 3.41B 6.4B 438B 6.42B 45.04B 17.38B 223B 17.15B 16.77B 717B
Net income 1,536B 1.11B 964M 910M 826M 1.55B 106B 1.55B 10.9B 4.21B 53.92B 4.15B 4.06B 173B 1,785B 1.28B 1.12B 1.06B 961M 1.8B 123B 1.81B 12.67B 4.89B 62.68B 4.83B 4.72B 202B
Net Debt 2,224B 1.6B 1.4B 1.32B 1.2B 2.24B 154B 2.25B 15.79B 6.09B 78.09B 6.01B 5.88B 251B 1,371B 987M 860M 812M 738M 1.38B 94.66B 1.39B 9.73B 3.75B 48.13B 3.71B 3.62B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-17 179,400.00 -0.50% 634,484
26-09-17 ₩180,300.00 +1.75% 328,926
26-09-16 ₩177,200.00 -0.17% 259,646
26-09-15 ₩177,500.00 -0.73% 195,823
26-09-14 ₩178,800.00 +0.34% 396,196
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
179,400.00KRW
Average target price
268,686.76KRW
Spread / Average Target
+49.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!